I’m constantly on the hunt for solid swing trades like EONC, AXK, ABAT, CXZ, AMRI, TSON, EVC, GLCH, AMR and PNCL. Normally I try to position before the move like I did with HDY recently at $3.06 before it ran about 30% the following day, however, sometimes swimming with the current is an easy way to grab quick profits too.
Quantum Fuel Systems Technologies (Nasdaq: QTWW) and SBE Inc. today announced the formation of a technology partnership between the two companies. SBE will be providing a novel integrated capacitor/bus structure design solution for Quantum power electronics for automotive applications, enabling higher performance, weight reduction, smaller packaging and total system cost savings.
Strategic American Oil Corp. (OTCBB: SGCA), an aggressive, growth oriented energy company, announced its fiscal first quarter financial and operational results.
On Friday, Gunpowder Gold Corp. (OTCBB: GUNP) provided updated results for one of their claim blocks in their Dome Rock gold project in La Paz County, Arizona. Work included sediment and outcrop chip sampling from within Gunpowder Gold’s 100 percent owned BHR62 claim block.
Project geologists collected 16 rock chip and 22 sediment samples, all of which underwent submission for 34 element analysis by ICP (inductively-coupled plasma) and gold analysis by gold assay and ICP finish. Several of the samples were anomalous for copper and gold.
Rainbow BioSciences (OTCBB: RBCC) is a company on the rise. Located in Nokomis, Florida, Rainbow BioSciences has quickly made a name for themselves on Wall Street. A division of Rainbow Coral Corp., the young company has continually sought new partnerships with biotechnology developers to deliver new medical technologies and innovations. Friday, Rainbow BioSciences announced they have begun due diligence for potential acquisition or joint venture with n3D Biosciences, Inc.
n3D is known as a developer of a revolutionary nonparticle cell-growth technology and offers a tremendous opportunity for the future of cell research for both companies.
As the silver and gold price predictably fade ahead of option expiration, JP Morgan’s bullion manipulation scheme could be headed for unprecedented problems, not from the record purchases of gold and silver from the Chinese, Indians or Russians, but from one Canadian billionaire.
Canadian-based Eric Sprott Management CEO Eric Sprott filed a follow up prospectus for the purchase of an additional $1.5 billion of silver bullion to cover expected demand for the company’s exchange traded fund, PSLV. Sign-up for my 100% FREE Alerts
Posted by Stock Analyzer posted on the 15th December 2011

Morning Traders! Let me first start by saying "congratulations" to all of my SuperNova members that have had five or six consecutive double digit gains over the last week or two which is a pretty big thing to do in this limp market.

ABOT 1.6 million dollar pump is on!

Posted by Stock Analyzer posted on the 16th December 2011

Ok here we go again! A small penny pump with a million dollar budget that's picking up all the small cap attention. Yes ABOT is making 200% gains today but lets be honest, the stock just got FLUSHED from nearly $.10 cents a day or two ago for this very reason. The old sling shot trick is what I call it. Now I don't know this for sure so this is all pure opinion but my guess would be the promo team finds a way to sink the share price just a day or two before the campaign starts. Then they run it up 200% (which is still 50% lower for those in at $.10 a day or two ago) and they claim victory. I mean I guess that works.

But as always, the big question remains...Where does ABOT go from here?

Technically speaking the stock has resistance at $.08 $.085 and $.095 ahead with no support until $.006. So will the stock hit $.006 soon? Well maybe not in the next day or two because the million dollar pump won't let it but check back to this post in a week or two and I bet you see it near that level.

Continue Reading »»

Featured Company

Apricus Biosciences, Inc. (Nasdaq:APRI)

SAN DIEGO, Aug. 11, 2011 (GLOBE NEWSWIRE) – Apricus Biosciences, Inc. (“Apricus Bio” or the “Company”) (Nasdaq:APRI) (http://www.apricusbio.com) announced today that Chairman, President and Chief Executive Officer, Dr. Bassam Damaj, was interviewed recently by the CEO Roadshow financial network (http://www.ceoroadshow/). During the interview, Dr. Damaj reported on plans for the Company’s pipeline, including the proposed commercialization in Canada and Europeof Vitaros®, a topical treatment for erectile dysfunction. Disclaimer

December 18, 2011 8:40 PMWatch now

Copyright © 2012 CEO Roadshow All Rights Reserved.    Terms of Use  •  Privacy Policy  •  Site Map

Viestly
CEORoadshow.com is a compensated financial public relations company which is committed to producing the highest-quality insight and analysis of penny stocks, emerging technology stocks, small cap stocks and helping investors make informed decisions. Trade stocks Jim Cramer style.